More on EDSA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+42.3% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (11/14/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Edesa Biotech (NQ:EDSA)
Delayed: 7.35 +0.47 (6.83%)
Prev. Close $6.88  
Open$6.94 
52 Wk High$ 
52 Wk Low$ 
Day High$7.60 
Day Low$6.56 
P/E N/A  
EPS$ 
Volume258,619 

Friends, Peers and Foes (?): CPH NPTH (more...)

Jun 18, 2026 05:06 PM Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: INTEGRATED CORE STRATEGIES (US) LLC
Jun 16, 2026 05:07 PM Form SCHEDULE 13D/A Edesa Biotech, Inc. Filed by: Nijhawan Pardeep
Jun 16, 2026 05:03 PM Form 4 Edesa Biotech, Inc. For: Jun 16 Filed by: Nijhawan Pardeep
Jun 11, 2026 09:20 AM Form 8-K Edesa Biotech, Inc. For: Jun 10
Jun 11, 2026 09:15 AM Edesa Biotech raises $3.5 million in private placement led by CEO
Jun 11, 2026 09:15 AM Edesa Biotech Announces $3.5 Million Private Placement of Common Shares Led by CEO and Healthcare-Focused Investors
Jun 5, 2026 09:26 AM Edesa Biotech reports exploratory data on drug for kidney injury
Jun 5, 2026 09:25 AM Form 8-K Edesa Biotech, Inc. For: Jun 05
Jun 5, 2026 09:20 AM Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
Jun 1, 2026 05:00 PM Form 4 Edesa Biotech, Inc. For: Jun 01 Filed by: Nijhawan Pardeep
View All Articles

Entities mentioned with EDSA

View All Entities